2020 was the beginning of the trials with cbd/tpm formulation. In vitro trials should large increase in absorption, market reacted and then headed back down when the reality of how long the clinical program takes. we are now on the final stages. 75 patients in phase 3 at the end of December. Need 3x that for interim results. If/when they get to that number and the results are positive SP will jump. If not the end of AVE. all this recent movement is speculation around a deal to provide funding to complete the trial without which they are stuffed.
AVE Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)